Is Adobe (ADBE) Offering An Opportunity After Its Recent Share Price Slide?

  • If you are wondering whether Adobe's current share price offers value or just more volatility, you are not alone. This article is built to help you frame that question clearly.
  • Adobe's share price closed at US$296.12, with returns of an 11.3% decline over 7 days, a 16.5% decline over 30 days, an 11.2% decline year to date, a 31.1% decline over 1 year, a 16.9% decline over 3 years and a 37.3% decline over 5 years. This performance has sharpened the focus on what the stock might be worth today.
  • Recent coverage has centered on Adobe as a key software name in major U.S. indices and as a widely followed benchmark in creative and productivity software. This context has kept attention on how investors are weighing Adobe's long term role in software against its current share price moves.
  • On Simply Wall St's valuation checks, Adobe scores 5 out of 6 for being assessed as undervalued. Next, we will look at what different valuation approaches are saying today before finishing with an even more practical way to think about Adobe's value.

Find out why Adobe's -31.1% return over the last year is lagging behind its peers.

Advertisement

Approach 1: Adobe Discounted Cash Flow (DCF) Analysis

A DCF model takes estimates of the cash a business could generate in the future and discounts those cash flows back to today, aiming to arrive at an estimate of what the whole company might be worth in the present.

For Adobe, the model used is a 2 Stage Free Cash Flow to Equity approach. The latest twelve month free cash flow is about US$9.5b. Simply Wall St uses analyst projections where available, then extends those forecasts further out. In Adobe's case, projected free cash flow for 2030 is US$13.0b, based on a mix of analyst estimates out to 2029 and extrapolated figures beyond that.

When all these future cash flows are discounted back to today, the DCF output suggests an estimated intrinsic value of around US$519.57 per share. Compared with the current share price of US$296.12, this implies an intrinsic discount of about 43.0%, which points to Adobe trading below this DCF estimate.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Adobe is undervalued by 43.0%. Track this in your watchlist or portfolio, or discover 863 more undervalued stocks based on cash flows.

ADBE Discounted Cash Flow as at Jan 2026
ADBE Discounted Cash Flow as at Jan 2026

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Adobe.

Approach 2: Adobe Price vs Earnings

For a profitable company like Adobe, the P/E ratio is a useful way to think about value because it links what you pay directly to the earnings the business is generating today.

What counts as a reasonable P/E depends a lot on what the market expects for future growth and how risky those earnings are. Higher growth and perceived stability often go with higher P/E ratios, while lower growth or higher risk usually come with lower P/E ratios.

Adobe currently trades on a P/E of 17.39x. That sits below the broader Software industry average of 32.35x and also below a peer group average of 55.42x. Simply Wall St also calculates a “Fair Ratio” of 34.39x for Adobe, which is the P/E level its model suggests could be reasonable given factors like earnings growth, profit margins, industry, market cap and company specific risks.

This Fair Ratio can be more informative than a simple peer or industry comparison because it adjusts for Adobe’s own characteristics rather than assuming it should match a broad group.

With the current P/E of 17.39x sitting below the Fair Ratio of 34.39x, this approach points to the shares looking undervalued on earnings.

Result: UNDERVALUED

NasdaqGS:ADBE P/E Ratio as at Jan 2026
NasdaqGS:ADBE P/E Ratio as at Jan 2026

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Discover 1445 companies where insiders are betting big on explosive growth.

Upgrade Your Decision Making: Choose your Adobe Narrative

Earlier we mentioned that there is an even better way to understand valuation, so let us introduce Narratives, which let you attach a clear story about Adobe to the numbers you care about, such as your own fair value, revenue, earnings and margin assumptions.

A Narrative on Simply Wall St is your view of how Adobe’s business might develop, linked directly to a financial forecast and a fair value estimate, then compared with today’s share price so you can judge whether the stock looks expensive or cheap against your own numbers.

These Narratives sit inside the Simply Wall St Community page, are used by millions of investors, update automatically as new earnings or news arrive, and make it easy to see, for example, how one Adobe Narrative could lean cautious with a fair value of about US$271.93 while another is more optimistic at about US$585.69. This gives you a concrete range of views to compare with your own.

For Adobe however we will make it really easy for you with previews of two leading Adobe Narratives:

🐂 Adobe Bull Case

Fair value in this narrative: US$383.06 per share

Implied undervaluation versus the recent price of US$296.12: about 22.7%

Revenue growth used in this narrative: 8.12%

  • Frames Adobe as a high quality business facing tougher competition, but still underpinned by strong profitability and balance sheet metrics.
  • Uses a multi scenario valuation map across bear, base and bull cases to arrive at a weighted fair value that is above the current share price.
  • Assumes mid single digit to low double digit revenue growth, resilient margins and a lower but still supportive future P/E multiple compared with past levels.

🐻 Adobe Bear Case

Fair value in this narrative: about US$271.93 per share

Implied overvaluation versus the recent price of US$296.12: about 8.9%

Revenue growth used in this narrative: 6.66%

  • Takes the more cautious end of analyst assumptions on growth, margins and valuation, resulting in a fair value that sits below the recent share price.
  • Highlights rising AI and product investment, potential margin pressure and the risk that new subscription tiers and features do not fully meet expectations.
  • Stresses competition from other software and AI tools, as well as the possibility that Adobe trades on a lower P/E multiple if these risks weigh on sentiment.

These two Narratives give you a clear range, from a constructive underpriced view to a more cautious, near fully priced view, so you can sense check your own assumptions against both sides.

Curious how numbers become stories that shape markets? Explore Community Narratives

Do you think there's more to the story for Adobe? Head over to our Community to see what others are saying!

NasdaqGS:ADBE 1-Year Stock Price Chart
NasdaqGS:ADBE 1-Year Stock Price Chart

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqGS:ADBE

Adobe

Operates as a technology company worldwide.

Undervalued with adequate balance sheet.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1156.7% undervalued
51 users have followed this narrative
2 users have commented on this narrative
9 users have liked this narrative
BL
BlackGoat
IREN logo
BlackGoat on IREN ·

IREN's Bold Moves in Sustainable Bitcoin Mining & AI Data Centers

Fair Value:US$71.4852.5% undervalued
205 users have followed this narrative
6 users have commented on this narrative
32 users have liked this narrative
HE
HedgeY
ARM logo
HedgeY on Arm Holdings ·

The Architecture Layer of AI Computing - But Priced Like the Future Already Arrived?

Fair Value:US$43043.1% undervalued
9 users have followed this narrative
1 users have commented on this narrative
3 users have liked this narrative
HI
Hidden_Rock_Capital
FISV logo
Hidden_Rock_Capital on Fiserv ·

Temporary "perfect storm" leads to opportunity to buy financial services leader for less than 5x long-term earnings

Fair Value:US$119.9954.8% undervalued
13 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative

Updated Narratives

ON
LOT logo
Ontological on Lotus Technology ·

Lotus Tech, Finloop and FOMO Pay Collaborate to Explore Vehicle Tokenization

Fair Value:US$2.463.7% undervalued
1 users have followed this narrative
1 users have commented on this narrative
0 users have liked this narrative
NE
AIIO logo
newsfinder11221 on Robo.ai ·

Robo.ai (NASDAQ: AIIO): Building the Infrastructure Behind the AI Revolution

Fair Value:US$539.3% undervalued
1 users have followed this narrative
3 users have commented on this narrative
0 users have liked this narrative
EU
European_Hidden_Gem_Stocks
ALMIN logo
European_Hidden_Gem_Stocks on MINT Société anonyme ·

Mint SA: A French Micro-Cap Energy Retailer Worth Watching

Fair Value:€1153.1% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.916.3% undervalued
88 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28029.6% undervalued
199 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6510.3% undervalued
73 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0